Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 1,034 | 652 | 1,668 | 1,162 | 780 |
| Cost of Goods | 84 | 20 | 36 | 19 | 25 |
| Gross Profit | 950 | 632 | 1,632 | 1,143 | 756 |
| Operating Expenses | 7,113 | 6,568 | 7,115 | 5,394 | 5,761 |
| Operating Income | -6,079 | -5,916 | -5,447 | -4,232 | -4,981 |
| Other Income | 85 | -319 | 185 | -4 | -19 |
| Pre-tax Income | -5,994 | -6,234 | -5,262 | -4,237 | -5,000 |
| Net Income Continuous | -5,994 | -6,234 | -5,262 | -4,237 | -5,000 |
| Minority Interests | -537 | -1,261 | -124 | -499 | -722 |
| Net Income | $-5,457 | $-4,973 | $-5,138 | $-3,738 | $-4,278 |
| EPS Basic Total Ops | -0.11 | -0.10 | -0.11 | -0.08 | -0.09 |
| EPS Basic Continuous Ops | -0.12 | -0.13 | -0.12 | -0.09 | -0.10 |
| EPS Diluted Total Ops | -0.11 | -0.10 | -0.11 | -0.08 | -0.09 |
| EPS Diluted Continuous Ops | -0.12 | -0.13 | -0.12 | -0.09 | -0.10 |
| EBITDA(a) | $-5,447 | $-5,108 | $-4,674 | $-3,639 | $-4,145 |